2026 Global: Medical Duodenal Stent Market -Competitive Review (2032) report
Description
The 2026 Global: Medical Duodenal Stent Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Boston Scientific Corporation, a leading supplier of gastrointestinal implants, is headquartered in Marlborough, Massachusetts, United States and has a global portfolio that includes the WallFlex Enteral Stent used for duodenal obstruction. Cook Medical, headquartered in Bloomington, Indiana, United States, offers enteral stents that address malignant gastric outlet obstruction, supporting palliative care strategies with a focus on endoscopy and minimally invasive deployment. Taewoong Medical Co., Ltd., based in Seoul, South Korea, develops Niti-S enteral stents with a range of covered and uncovered configurations designed for duodenal applications and to optimize conformability in variable luminal anatomies. M.I. Tech Co., Ltd., headquartered in Seoul, South Korea, supplies self-expanding enteral stents and related delivery systems, emphasizing flexibility, trackability, and radiopacity to facilitate navigation through the duodenum. Together these manufacturers constitute a core segment of the contemporary duodenal stent market, reflecting Asia-Pacific leadership and diversified device portfolios that support diverse clinical indications and geographic adoption.
Olympus Corporation, headquartered in Tokyo, Japan, extends its medical technology footprint into gastrointestinal interventions with endoscopic devices and stent platforms that complement diagnostic and therapeutic capabilities for duodenal obstructions. Biosensors International, headquartered in Singapore, delivers enteral and biliary stents through a global distribution network, emphasizing cross-continent adoption and cross-functional compatibility with endoscopy suites. ConMed Corporation, based in Utica, New York, United States, markets a range of enteral stents and delivery systems that integrate with contemporary endoscopic practice and provide options for various duodenal anatomies and disease states. The combination of these players expands the regional and procedural reach of duodenal stenting, enabling endoscopists to select from an array of designs, coverings, and delivery modalities. Collectively, the presence of Olympus, Biosensors, and ConMed reflects the maturation of the market as a multi-sponsor, technology-driven field with global distribution and clinical education programs. These brands contribute to standardized training and broader patient access.
B. Braun Melsungen AG, headquartered in Melsungen, Germany, maintains a comprehensive portfolio of enteral stents and related delivery systems that support dual indications in malignant and benign duodenal obstruction and integrate with companion devices for endoscopic workflows. Micro-Tech Endoscopy (Nanjing) Co., Ltd., based in Nanjing, China, markets a broad line of self-expanding gastrointestinal stents, including duodenal configurations, designed for robust deliverability and radiopacity. S&G Biotech, Inc., headquartered in New Taipei City, Taiwan, offers enteral stents featuring covered and uncovered designs intended to address complex luminal strictures and improve deployment precision. Collectively, these manufacturers reinforce the geographic diversity of the field, with Europe, East Asia, and North America driving innovation, standardization, and cross-regional clinical training. The resulting market configuration supports durable patient access to palliative and palliative-intent interventions, fosters competitive differentiation, and underpins ongoing research into materials, scaffolds, and stent coatings for duodenal applications. Clinical adoption continues to shift toward personalization.
Boston Scientific Corporation, a leading supplier of gastrointestinal implants, is headquartered in Marlborough, Massachusetts, United States and has a global portfolio that includes the WallFlex Enteral Stent used for duodenal obstruction. Cook Medical, headquartered in Bloomington, Indiana, United States, offers enteral stents that address malignant gastric outlet obstruction, supporting palliative care strategies with a focus on endoscopy and minimally invasive deployment. Taewoong Medical Co., Ltd., based in Seoul, South Korea, develops Niti-S enteral stents with a range of covered and uncovered configurations designed for duodenal applications and to optimize conformability in variable luminal anatomies. M.I. Tech Co., Ltd., headquartered in Seoul, South Korea, supplies self-expanding enteral stents and related delivery systems, emphasizing flexibility, trackability, and radiopacity to facilitate navigation through the duodenum. Together these manufacturers constitute a core segment of the contemporary duodenal stent market, reflecting Asia-Pacific leadership and diversified device portfolios that support diverse clinical indications and geographic adoption.
Olympus Corporation, headquartered in Tokyo, Japan, extends its medical technology footprint into gastrointestinal interventions with endoscopic devices and stent platforms that complement diagnostic and therapeutic capabilities for duodenal obstructions. Biosensors International, headquartered in Singapore, delivers enteral and biliary stents through a global distribution network, emphasizing cross-continent adoption and cross-functional compatibility with endoscopy suites. ConMed Corporation, based in Utica, New York, United States, markets a range of enteral stents and delivery systems that integrate with contemporary endoscopic practice and provide options for various duodenal anatomies and disease states. The combination of these players expands the regional and procedural reach of duodenal stenting, enabling endoscopists to select from an array of designs, coverings, and delivery modalities. Collectively, the presence of Olympus, Biosensors, and ConMed reflects the maturation of the market as a multi-sponsor, technology-driven field with global distribution and clinical education programs. These brands contribute to standardized training and broader patient access.
B. Braun Melsungen AG, headquartered in Melsungen, Germany, maintains a comprehensive portfolio of enteral stents and related delivery systems that support dual indications in malignant and benign duodenal obstruction and integrate with companion devices for endoscopic workflows. Micro-Tech Endoscopy (Nanjing) Co., Ltd., based in Nanjing, China, markets a broad line of self-expanding gastrointestinal stents, including duodenal configurations, designed for robust deliverability and radiopacity. S&G Biotech, Inc., headquartered in New Taipei City, Taiwan, offers enteral stents featuring covered and uncovered designs intended to address complex luminal strictures and improve deployment precision. Collectively, these manufacturers reinforce the geographic diversity of the field, with Europe, East Asia, and North America driving innovation, standardization, and cross-regional clinical training. The resulting market configuration supports durable patient access to palliative and palliative-intent interventions, fosters competitive differentiation, and underpins ongoing research into materials, scaffolds, and stent coatings for duodenal applications. Clinical adoption continues to shift toward personalization.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
